FOLH1 and pachyonychia congenita: Therefore, we are convinced that an analysis of SUV based on PSMA-RADS may be helpful for stratifying the risk of PC involvement, in particular for lymph nodes and for the discrimination of equivocal PSMA-RADS-3B lesions in the bone.